The DOI matches its Crossref record.
Prostaglandin E2 differentially modulates cytokine secretion profiles of human T helper lymphocytes
Abstract
PGE2 is a well known immunomodulator that has multiple effects on the immune system. We demonstrate that PGE2 selectively and dose dependently inhibits IL-2 and IFN-gamma production by mitogenically stimulated human PBL and CD4+ TLC, although at low concentrations IL-4 production is not affected and IL-5 production is even up-regulated. In the tested TLC, PGE2 induced a dramatic elevation (up to 85-fold) of the intracellular cAMP levels. The action of PGE2 may, therefore, be associated with elevation of intracellular cAMP levels, affecting IL-4 and IL-5 differentially from IL-2 and IFN-gamma production. To test this hypothesis we investigated cytokine production by TLC in the absence or presence of agents that affect cAMP levels, either directly (2’-O-dibutyrylcAMP) or through activation of adenylate cyclase (forskolin) or by blocking of phosphodiesterase (3-isobutyl-1-methyl-xanthine). Similar to PGE2, forskolin, 2’-O-dibutyrylcAMP, and 3-isobutyl-1-methyl-xanthine induced inhibition of IL-2 production by TLC and up-regulation of IL-5 production. However, in contrast to PGE2, these agents suppressed IL-4 production although IFN-gamma production was only moderately affected. No significant differences were found between intracellular cAMP levels of mitogenically stimulated Th1 cell clones, which predominantly secrete IL-2 and IFN-gamma, and those of Th2 cell clones, which mainly secrete IL-4 and IL-5. Our results indicate that PGE2 selectively modulates cytokine secretion profiles of human T cells and that elevation of cAMP levels has an important, but possibly not exclusive, regulatory role in this phenomenon.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Allergic Rhinitis and Its Impact on Asthma
Bousquet, J., van Cauwenberge, P., & Khaltaev, N. (2001) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2001.118891 · Cited by 3,588
Wang, D., & DuBois, R. N. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2809 · Cited by 1,793
Regulation of Immune Responses by Prostaglandin E2
Kalinski, P. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1101029 · Cited by 1,474
Origin, maturation and antigen presenting function of dendritic cells
Cella, M., Sallusto, F., & Lanzavecchia, A. (1997) · Current Opinion in Immunology · doi:10.1016/s0952-7915(97)80153-7 · Cited by 1,320
Penna, G., & Adorini, L. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.5.2405 · Cited by 1,267
Boonstra, A., Barrat, F. J., Crain, C., Heath, V. L., Savelkoul, H. F. J., & O’Garra, A. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.9.4974 · Cited by 1,123
Navigating metabolic pathways to enhance antitumour immunity and immunotherapy
Li, X., Wenes, M., Romero, P., Huang, S. C.-C., Fendt, S.-M., & Ho, P.-C. (2019) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-019-0203-7 · Cited by 733
Prostaglandin-E2 is a potent inhibitor of human interleukin 12 production.
van der Pouw Kraan, T. C., Boeije, L. C., Smeenk, R. J., Wijdenes, J., & Aarden, L. A. (1995) · The Journal of experimental medicine · doi:10.1084/jem.181.2.775 · Cited by 666
Zhang, D.-H., Cohn, L., Ray, P., Bottomly, K., & Ray, A. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.34.21597 · Cited by 665
Phosphodiesterase Isozymes: Molecular Targets for Novel Antiasthma Agents
TORPHY, T. J. (1998) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.157.2.9708012 · Cited by 657
Madrigal, M., Rao, K. S., & Riordan, N. H. (2014) · Journal of Translational Medicine · doi:10.1186/s12967-014-0260-8 · Cited by 615
Multifaceted roles of PGE2 in inflammation and cancer
Nakanishi, M., & Rosenberg, D. W. (2013) · Seminars in Immunopathology · doi:10.1007/s00281-012-0342-8 · Cited by 591
Dunstan, J. A., Mori, T. A., Barden, A., Beilin, L. J., Taylor, A. L., Holt, P. G., & Prescott, S. L. (2003) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2003.09.009 · Cited by 520
CD28-B7 blockade after alloantigenic challenge in vivo inhibits Th1 cytokines but spares Th2.
Sayegh, M. H., Akalin, E., Hancock, W. W., Russell, M. E., Carpenter, C. B., Linsley, P. S., & Turka, L. A. (1995) · The Journal of experimental medicine · doi:10.1084/jem.181.5.1869 · Cited by 511
Dietary fat and asthma: is there a connection?
Black, P., & Sharpe, S. (1997) · European Respiratory Journal · doi:10.1183/09031936.97.10010006 · Cited by 491
Dietary modification of inflammation with lipids
Calder, P. C. (2002) · Proceedings of the Nutrition Society · doi:10.1079/pns2002166 · Cited by 485
Boniface, K., Bak-Jensen, K. S., Li, Y., Blumenschein, W. M., McGeachy, M. J., McClanahan, T. K., McKenzie, B. S., Kastelein, R. A., Cua, D. J., & de Waal Malefyt, R. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20082293 · Cited by 479
Anti-inflammatory mechanisms of methotrexate in rheumatoid arthritis
CUTOLO, M., SULLI, A., PIZZORNI, C., SERIOLO, B., & STRAUB, R. H. (2001) · Annals of the Rheumatic Diseases · doi:10.1136/ard.60.8.729 · Cited by 433
Interferon-γ: Biology and Role in Pathogenesis
Billiau, A. (1996) · Advances in Immunology · doi:10.1016/s0065-2776(08)60428-9 · Cited by 433
The innate immune response of the respiratory epithelium: Innate immunity in the airway
Diamond, G., Legarda, D., & Ryan, L. K. (2000) · Immunological Reviews · doi:10.1034/j.1600-065x.2000.917304.x · Cited by 422
Role of Zinc in Immune System and Anti-Cancer Defense Mechanisms
Skrajnowska, D., & Bobrowska-Korczak, B. (2019) · Nutrients · doi:10.3390/nu11102273 · Cited by 414
Lee, H. J., Takemoto, N., Kurata, H., Kamogawa, Y., Miyatake, S., O'Garra, A., & Arai, N. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.1.105 · Cited by 393
“There is also an indication that cAMP levels are higher in Th2 cells than in Th1 cells (30) and that molecules that elevate intracellular cAMP inhibit cytokine production by Th1 cells and conversely augment cytokine production by Th2 cells (31, 32).”
BackgroundA two-step induction of indoleamine 2,3 dioxygenase (IDO) activity during dendritic-cell maturation
Braun, D., Longman, R. S., & Albert, M. L. (2005) · Blood · doi:10.1182/blood-2005-03-0979 · Cited by 391
Harizi, H., Juzan, M., Pitard, V., Moreau, J.-F., & Gualde, N. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.5.2255 · Cited by 384
Kaliński, P., Vieira, P. L., Schuitemaker, J. H. N., de Jong, E. C., & Kapsenberg, M. L. (2001) · Blood · doi:10.1182/blood.v97.11.3466 · Cited by 362
Self-citationDendorfer, U., Oettgen, P., & Libermann, T. A. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.7.4443 · Cited by 332
Role of Antibiotics and Fungal Microbiota in Driving Pulmonary Allergic Responses
Noverr, M. C., Noggle, R. M., Toews, G. B., & Huffnagle, G. B. (2004) · Infection and Immunity · doi:10.1128/iai.72.9.4996-5003.2004 · Cited by 330
Zhang, D.-H., Yang, L., Cohn, L., Parkyn, L., Homer, R., Ray, P., & Ray, A. (1999) · Immunity · doi:10.1016/s1074-7613(00)80122-3 · Cited by 325
Harbige, L. S. (2003) · Lipids · doi:10.1007/s11745-003-1067-z · Cited by 320
Xia, Z., Depierre, J. W., & Nässberger, L. (1996) · Immunopharmacology · doi:10.1016/0162-3109(96)00111-7 · Cited by 318
The lung as a privileged site for the beneficial actions of PGE2
Vancheri, C. (2004) · Trends in Immunology · doi:10.1016/j.it.2003.11.001 · Cited by 313
Macrophages and post-burn immune dysfunction
Schwacha, M. G. (2003) · Burns · doi:10.1016/s0305-4179(02)00187-0 · Cited by 310
Inhibition of maturation and function of dendritic cells by intravenous immunoglobulin
Bayry, J., Lacroix-Desmazes, S., Carbonneil, C., Misra, N., Donkova, V., Pashov, A., Chevailler, A., Mouthon, L., Weill, B., Bruneval, P., et al. (2003) · Blood · doi:10.1182/blood-2002-05-1447 · Cited by 306
Biochemistry of Cyclooxygenase (COX)-2 Inhibitors and Molecular Pathology of COX-2 in Neoplasia
Fosslien, E. (2000) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408360091174286 · Cited by 296
Lipoxygenase metabolism: roles in tumor progression and survival
Pidgeon, G. P., Lysaght, J., Krishnamoorthy, S., Reynolds, J. V., O’Byrne, K., Nie, D., & Honn, K. V. (2007) · Cancer and Metastasis Reviews · doi:10.1007/s10555-007-9098-3 · Cited by 295
IL-18–induced CD83+CCR7+NK helper cells
Mailliard, R. B., Alber, S. M., Shen, H., Watkins, S. C., Kirkwood, J. M., Herberman, R. B., & Kalinski, P. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050128 · Cited by 286
Rieser, C., Böck, G., Klocker, H., Bartsch, G., & Thurnher, M. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.9.1603 · Cited by 274
Reprogramming the tumor microenvironment: tumor-induced immunosuppressive factors paralyze T cells
Wu, A. A., Drake, V., Huang, H.-S., Chiu, S., & Zheng, L. (2015) · OncoImmunology · doi:10.1080/2162402x.2015.1016700 · Cited by 271
Newberry, R. D., Stenson, W. F., & Lorenz, R. G. (1999) · Nature Medicine · doi:10.1038/11341 · Cited by 264
Fibroblast heterogeneity in tumor micro-environment: Role in immunosuppression and new therapies
Mhaidly, R., & Mechta-Grigoriou, F. (2020) · Seminars in Immunology · doi:10.1016/j.smim.2020.101417 · Cited by 259
Mhaidly, R., & Mechta‐Grigoriou, F. (2021) · Immunological Reviews · doi:10.1111/imr.12978 · Cited by 231
The role of the sympathetic nervous system in intestinal inflammation
Straub, R. H., Wiest, R., Strauch, U. G., Härle, P., & Schölmerich, J. (2006) · Gut · doi:10.1136/gut.2006.091322 · Cited by 237
Cutting edge: differential production of prostaglandin D2 by human helper T cell subsets
Tanaka, K., Ogawa, K., Sugamura, K., Nakamura, M., Takano, S., & Nagata, K. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.5.2277 · Cited by 204
Role of PLB1 in Pulmonary Inflammation and Cryptococcal Eicosanoid Production
Noverr, M. C., Cox, G. M., Perfect, J. R., & Huffnagle, G. B. (2003) · Infection and Immunity · doi:10.1128/iai.71.3.1538-1547.2003 · Cited by 133
Calder, P. C. (2010) · Clinical Nutrition · doi:10.1016/j.clnu.2009.11.003 · Cited by 81
Metadata
- Authors
- Snijdewint, F. G., Kaliński, P., Wierenga, E. A., Bos, J. D., & Kapsenberg, M. L.
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 1993-06
- Volume
- 150
- Issue
- 12
- Pages
- 5321-5329
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W1647832452
- Cited by
- 477
- References
- 0
- FWCI
- 15.29
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.